Skip to main content
. 2012 Feb 8;7(2):e31188. doi: 10.1371/journal.pone.0031188

Figure 1. Injection of rLOX-PP inhibits NF639 xenograft growth in mice.

Figure 1

(A) Subcutaneous xenografts of NF639 breast cancer cells were injected once daily with 10 micrograms rLOX-PP for 5 days beginning on day 17 (arrows). Tumor volumes were monitored by caliper measurements (n = 10; *, p<0.05); (B) The tumor growth rates were determined from measurements made beginning on day 18 and were derived from linear regression analyses of the data. (C) Tumor weights at sacrifice on day 25 (p = 0.4, n = 10).